The estimated Net Worth of Kenneth Burhop is at least 276 千$ dollars as of 30 July 2019. Dr Burhop owns over 6,656 units of Integra Lifesciences Corp stock worth over 275,704$ and over the last 10 years he sold IART stock worth over 0$.
Sign up
Dr D IART stock SEC Form 4 insiders trading
Dr has made over 1 trades of the Integra Lifesciences Corp stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 6,656 units of IART stock worth 197,151$ on 30 July 2019.
The largest trade he's ever made was exercising 6,656 units of Integra Lifesciences Corp stock on 30 July 2019 worth over 197,151$. On average, Dr trades about 392 units every 0 days since 2015. As of 30 July 2019 he still owns at least 15,665 units of Integra Lifesciences Corp stock.
You can see the complete history of Dr Burhop stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr. Kenneth E. Burhop Ph.D. biography
Dr. Kenneth E. Burhop Ph.D. is the Corp. VP & Chief Scientific Officer at Integra Lifesciences Corp.
How old is Dr D?
Dr D is 67, he's been the Corp. VP & Chief Scientific Officer of Integra Lifesciences Corp since . There are 3 older and 18 younger executives at Integra Lifesciences Corp. The oldest executive at Integra Lifesciences Holdings Corp is Dr. Richard E. Caruso, 78, who is the Founder and Chairman Emeritus.
What's Dr D's mailing address?
Kenneth's mailing address filed with the SEC is 1100 CAMPUS ROAD, , PRINCETON, NJ, 08540.
Insiders trading at Integra Lifesciences Corp
Over the last 21 years, insiders at Integra Lifesciences Corp have traded over 397,927,161$ worth of Integra Lifesciences Corp stock and bought 132,879 units worth 4,504,827$ . The most active insiders traders include Neal Moszkowski、Stuart Essig、George Soros. On average, Integra Lifesciences Corp executives and independent directors trade stock every 19 days with the average trade being worth of 668,131$. The most recent stock trade was executed by Jeffrey Mosebrook on 19 August 2024, trading 1,191 units of IART stock currently worth 25,702$.
What does Integra Lifesciences Corp do?
integra lifesciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. in the united states, integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. founded in 1989 integra is headquartered in plainsboro, new jersey and has over 3,500 employees worldwide. integra's common stock is li
What does Integra Lifesciences Corp's logo look like?
Complete history of Dr Burhop stock trades at Integra Lifesciences Corp
Integra Lifesciences Corp executives and stock owners
Integra Lifesciences Corp executives and other stock owners filed with the SEC include:
-
Peter Arduini,
President, Chief Executive Officer, Director -
Glenn Coleman,
Chief Operating Officer, Executive Vice President -
Carrie Anderson,
Chief Financial Officer, Executive Vice President -
Eric Schwartz,
Executive Vice President, Chief Legal Officer, Secretary -
Robert Davis,
Executive Vice President, President - Orthopedics and Tissue Technologies -
Glenn G. Coleman,
Exec. VP & COO -
Carrie L. Anderson,
Exec. VP, CFO & Treasurer -
Robert T. Davis Jr.,
Exec. VP and Pres of Orthopedics & Tissue Technologies -
Stuart Essig,
Independent Chairman of the Board -
Rhonda Ballintyn,
Independent Director -
Barbara Hill,
Independent Presiding Director -
Christian Schade,
Independent Director -
Donald Morel,
Independent Director -
Lloyd Howell,
Independent Director -
Keith Bradley,
Independent Director -
Raymond Murphy,
Independent Director -
Michael Beaulieu,
IR Contact Officer -
Jeffrey Mosebrook,
Senior Vice President, Principal Accounting Officer -
Michael McBreen,
Executive Vice President and President - Codman Specialty Surgical -
Lisa Evoli,
Executive Vice President, Chief Human Resources Officer -
Eric Ian Schwartz,
Exec. VP, Chief Legal Officer & Sec. -
William Compton,
Chief Information Officer & Sr. VP -
Dr. Kenneth E. Burhop Ph.D.,
Corp. VP & Chief Scientific Officer -
Jeffrey Mosebrook,
Sr. VP, Principal Accounting Officer & Corp. Controller -
Dr. Richard E. Caruso,
Founder and Chairman Emeritus -
Jan De Witte,
Pres, CEO & Director -
James M Sullivan,
Director -
John Mooradian,
Corp VP, Global Ops & Supp Chn -
Judith Ogrady,
CorpVP,Global Reg.Affairs -
Kenneth Burhop,
CORPVP,CHIEFSCIENTIFIC OFFICER -
Mark A Augusti,
CVP,PRES-ORTHO & TISSUE TECH -
Richard D. Gorelick,
Corp VP, Gen Counsel & Sec -
Harvinder Singh,
EVP & PRESIDENT, INTERNATIONAL -
Chantal Veillon Berteloot,
EVP & CHRO -
Richard E Caruso,
10% owner -
Witte Jan De,
President & CEO -
Joseph Vinhais,
Corp VP,Quality&Transformation -
George Soros,
10% owner -
David B Holtz,
Sr. VP, Finance -
David C Auth,
Director -
Don R Nociolo,
Senior V.P., Operations -
Michael Piershbacher,
Senior VP, Research & Dev. -
Maureen B Bellantoni,
Exec V.P./CFO -
Neal Moszkowski,
Director -
Anne Vanlent,
Director -
Thomas J Jr Baltimore,
Director -
Daniel L. Reuvers,
CVP,PRES - CODMAN SPC SURGICAL -
Deborah A Leonetti,
Senior VP, Marketing -
Padma Thiruvengadam,
Corp VP, Chief HR Officer -
Robert D Paltridge,
Sr. VP, Global Sales -
Gerard S Carlozzi,
Exec. V.P., COO -
Brian Larkin,
Corp VP, Pres.Gbl Spine &Ortho -
John B Iii Henneman,
Exec. V.P., CAO, & Secretary -
Jerry E Corbin,
VP & Corporate Controller -
St Partnership, L.P. Tru,
10% owner -
Jeffrey A Graves,
Director -
Renee Wonlai Lo,
Director -
Lea Daniels Knight,
EVP & CHIEF FINANCIAL OFFICER